BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38892218)

  • 21. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of trimethylamine
    Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
    Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
    Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
    J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
    Gruppen EG; Garcia E; Connelly MA; Jeyarajah EJ; Otvos JD; Bakker SJL; Dullaart RPF
    Sci Rep; 2017 Oct; 7(1):13781. PubMed ID: 29061990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
    J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
    Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
    Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional study.
    Mafune A; Iwamoto T; Tsutsumi Y; Nakashima A; Yamamoto I; Yokoyama K; Yokoo T; Urashima M
    Clin Exp Nephrol; 2016 Oct; 20(5):731-739. PubMed ID: 26676906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke.
    Sun T; Zhang Y; Yin J; Peng X; Zhou L; Huang S; Wen Y; Cao B; Chen L; Li X; Yang W; Tan A; Cheng J; Liu L
    J Atheroscler Thromb; 2021 Apr; 28(4):320-328. PubMed ID: 32641646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma trimethylamine N-oxide and its metabolic precursors and risk of mortality, cardiovascular and renal disease in individuals with type 2-diabetes and albuminuria.
    Winther SA; Øllgaard JC; Hansen TW; von Scholten BJ; Reinhard H; Ahluwalia TS; Wang Z; Gæde P; Parving HH; Hazen S; Pedersen O; Rossing P
    PLoS One; 2021; 16(3):e0244402. PubMed ID: 33657115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma trimethylamine N-oxide levels with atherosclerotic cardiovascular disease and factors of the metabolic syndrome.
    Ringel C; Dittrich J; Gaudl A; Schellong P; Beuchel CF; Baber R; Beutner F; Teren A; Engel C; Wirkner K; Thiele H; Büttner P; Löffler M; Scholz M; Thiery J; Ceglarek U
    Atherosclerosis; 2021 Oct; 335():62-67. PubMed ID: 34583200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis.
    Fu D; Shen J; Li W; Wang Y; Zhong Z; Ye H; Huang N; Fan L; Yang X; Yu X; Zhou Y; Mao H
    Blood Purif; 2021; 50(6):837-847. PubMed ID: 33596582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study/Study of Latinos.
    Mei Z; Chen GC; Wang Z; Usyk M; Yu B; Baeza YV; Humphrey G; Benitez RS; Li J; Williams-Nguyen JS; Daviglus ML; Hou L; Cai J; Zheng Y; Knight R; Burk RD; Boerwinkle E; Kaplan RC; Qi Q
    Am J Clin Nutr; 2021 Jun; 113(6):1503-1514. PubMed ID: 33709132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients.
    Fukami K; Yamagishi S; Sakai K; Kaida Y; Yokoro M; Ueda S; Wada Y; Takeuchi M; Shimizu M; Yamazaki H; Okuda S
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):289-95. PubMed ID: 25636076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between elevated plasma trimethylamine N-oxide levels and increased stroke injury.
    Wu C; Xue F; Lian Y; Zhang J; Wu D; Xie N; Chang W; Chen F; Wang L; Wei W; Yang K; Zhao W; Wu L; Song H; Ma Q; Ji X
    Neurology; 2020 Feb; 94(7):e667-e677. PubMed ID: 31907287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loop diuretics decrease the renal elimination rate and increase the plasma levels of trimethylamine-N-oxide.
    Latkovskis G; Makarova E; Mazule M; Bondare L; Hartmane D; Cirule H; Grinberga S; Erglis A; Liepinsh E; Dambrova M
    Br J Clin Pharmacol; 2018 Nov; 84(11):2634-2644. PubMed ID: 30069897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimethylamine N-oxide and prognosis in acute heart failure.
    Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
    Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Trimethylamine N-Oxide Is Associated with Increased Risk of Cardiovascular Mortality in Type-2 Diabetes: Results from a Dutch Diabetes Cohort (ZODIAC-59).
    Flores-Guerrero JL; van Dijk PR; Connelly MA; Garcia E; Bilo HJG; Navis G; Bakker SJL; Dullaart RPF
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34073908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden.
    Stubbs JR; House JA; Ocque AJ; Zhang S; Johnson C; Kimber C; Schmidt K; Gupta A; Wetmore JB; Nolin TD; Spertus JA; Yu AS
    J Am Soc Nephrol; 2016 Jan; 27(1):305-13. PubMed ID: 26229137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
    Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
    ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.